Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trevor J Kilpatrick

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Neurorehabilitation|February 23, 2017
Gait and balance deterioration over a 12-month period in multiple sclerosis patients with EDSS scores ≤ 3.0Mary P Galea, L Eduardo Cofré Lizama, Helmut Butzkueven, et al.
Trends in Molecular Medicine|September 28, 2010
Therapeutic potential of LIF in multiple sclerosisHelena Slaets, Jerome J A Hendriks, Piet Stinissen, et al.
Journal of Neurochemistry|July 16, 2008
Neurotrophin receptor homolog-2 regulates nerve growth factor signalingAgnes W Wong, Melanie Willingham, Junhua Xiao, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 15, 2013
Oligodendroglial expression of TrkB independently regulates myelination and progenitor cell proliferationAgnes W Wong, Junhua Xiao, Dennis Kemper, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 25, 2011
Remyelination is altered by bone morphogenic protein signaling in demyelinated lesionsJennifer K Sabo, Tim D Aumann, Daniel Merlo, et al.
Expert Review of Neurotherapeutics|April 28, 2005
Neuroglial responses to CNS injury: prospects for novel therapeuticsTrevor J Kilpatrick, Helmut Butzkueven, Ben Emery, et al.
Plos One|February 25, 2011
Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibilityGerry Z M Ma, Jim Stankovich, , et al.
Glia|September 13, 2018
The TAM receptor TYRO3 is a critical regulator of myelin thickness in the central nervous systemFarrah Blades, Andrea Aprico, Rainer Akkermann, et al.
Optics Letters|December 11, 2013
Nanodiamonds with silicon vacancy defects for nontoxic photostable fluorescent labeling of neural precursor cellsTobias D Merson, Stefania Castelletto, Igor Aharonovich, et al.
Brain Plasticity (Amsterdam, Netherlands)|October 11, 2021
Identification and Characterisation of cis-Regulatory Elements Upstream of the Human Receptor Tyrosine Kinase Gene <i>MERTK</i>Alexander D Walsh, Laura J Johnson, Alexandra J Harvey, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Neurorehabilitation|February 23, 2017
Gait and balance deterioration over a 12-month period in multiple sclerosis patients with EDSS scores ≤ 3.0Mary P Galea, L Eduardo Cofré Lizama, Helmut Butzkueven, et al.
Trends in Molecular Medicine|September 28, 2010
Therapeutic potential of LIF in multiple sclerosisHelena Slaets, Jerome J A Hendriks, Piet Stinissen, et al.
Journal of Neurochemistry|July 16, 2008
Neurotrophin receptor homolog-2 regulates nerve growth factor signalingAgnes W Wong, Melanie Willingham, Junhua Xiao, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 15, 2013
Oligodendroglial expression of TrkB independently regulates myelination and progenitor cell proliferationAgnes W Wong, Junhua Xiao, Dennis Kemper, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 25, 2011
Remyelination is altered by bone morphogenic protein signaling in demyelinated lesionsJennifer K Sabo, Tim D Aumann, Daniel Merlo, et al.
Expert Review of Neurotherapeutics|April 28, 2005
Neuroglial responses to CNS injury: prospects for novel therapeuticsTrevor J Kilpatrick, Helmut Butzkueven, Ben Emery, et al.
Plos One|February 25, 2011
Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibilityGerry Z M Ma, Jim Stankovich, , et al.
Glia|September 13, 2018
The TAM receptor TYRO3 is a critical regulator of myelin thickness in the central nervous systemFarrah Blades, Andrea Aprico, Rainer Akkermann, et al.
Optics Letters|December 11, 2013
Nanodiamonds with silicon vacancy defects for nontoxic photostable fluorescent labeling of neural precursor cellsTobias D Merson, Stefania Castelletto, Igor Aharonovich, et al.
Brain Plasticity (Amsterdam, Netherlands)|October 11, 2021
Identification and Characterisation of cis-Regulatory Elements Upstream of the Human Receptor Tyrosine Kinase Gene <i>MERTK</i>Alexander D Walsh, Laura J Johnson, Alexandra J Harvey, et al.
Pageof 12